119 related articles for article (PubMed ID: 24486059)
1. Tissue microarrays in non-small-cell lung cancer: reliability of immunohistochemically-determined biomarkers.
Pøhl M; Olsen KE; Holst R; Ditzel HJ; Hansen O
Clin Lung Cancer; 2014 May; 15(3):222-230.e3. PubMed ID: 24486059
[TBL] [Abstract][Full Text] [Related]
2. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Mukhopadhyay S; Katzenstein AL
Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
Koh J; Go H; Kim MY; Jeon YK; Chung JH; Chung DH
Histopathology; 2014 Dec; 65(6):868-78. PubMed ID: 25130792
[TBL] [Abstract][Full Text] [Related]
4. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers.
Zachara-Szczakowski S; Verdun T; Churg A
Hum Pathol; 2015 May; 46(5):776-82. PubMed ID: 25776027
[TBL] [Abstract][Full Text] [Related]
6. Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer.
Jakobsen JN; Santoni-Rugiu E; Ravn J; Sørensen JB
Eur J Cancer; 2013 Jul; 49(11):2494-503. PubMed ID: 23639410
[TBL] [Abstract][Full Text] [Related]
7. Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.
Noh S; Shim H
Lung Cancer; 2012 Apr; 76(1):51-5. PubMed ID: 21978426
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin test.
Rüschoff J; Kerr KM; Grote HJ; Middel P; von Heydebreck A; Alves VA; Baldus SE; Büttner R; Carvalho L; Fink L; Jochum W; Lo AW; López-Ríos F; Marx A; Molina TJ; Olszewski WT; Rieker RJ; Volante M; Thunnissen E; Wrba F; Celik I; Störkel S
Arch Pathol Lab Med; 2013 Sep; 137(9):1255-61. PubMed ID: 23270410
[TBL] [Abstract][Full Text] [Related]
9. The clinical and pathological significance of RCAS1 expression as a prognostic biomarker in non-small cell lung cancer.
Tsoukalas N; Kostakis ID; Siakavellas S; Giaginis C; Bournakis E; Sfiniadakis I; Karameris A; Patsouris E; Theocharis S
In Vivo; 2014; 28(3):375-81. PubMed ID: 24815841
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study).
Toffart AC; Timsit JF; Couraud S; Merle P; Moro-Sibilot D; Perol M; Mastroianni B; Souquet PJ; Girard N; Jeannin G; Romand P; Chatellain P; Vesin A; Brambilla C; Brambilla E
Lung Cancer; 2014 Feb; 83(2):182-8. PubMed ID: 24388706
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Aikawa E; Kawahara A; Hattori S; Yamaguchi T; Abe H; Taira T; Azuma K; Kage M
Cancer Cytopathol; 2011 Oct; 119(5):335-45. PubMed ID: 21717589
[TBL] [Abstract][Full Text] [Related]
12. Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.
Pelosi G; Rossi G; Bianchi F; Maisonneuve P; Galetta D; Sonzogni A; Veronesi G; Spaggiari L; Papotti M; Barbareschi M; Graziano P; Decensi A; Cavazza A; Viale G
J Thorac Oncol; 2011 Jun; 6(6):1039-49. PubMed ID: 21512408
[TBL] [Abstract][Full Text] [Related]
13. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
Terry J; Leung S; Laskin J; Leslie KO; Gown AM; Ionescu DN
Am J Surg Pathol; 2010 Dec; 34(12):1805-11. PubMed ID: 21107086
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy.
Holgersson G; Ekman S; Reizenstein J; Bergqvist M; Pontén F; Uhlén M; Magnusson K; Jonnalagadda P; Asplund A; Strömberg S; Linder A; Blomquist E; Liljeholm M; Lödén B; Hellström K; Bergström S
Cancer Genomics Proteomics; 2010; 7(1):1-7. PubMed ID: 20181625
[TBL] [Abstract][Full Text] [Related]
15. Tissue microarrays are reliable tools for the clinicopathological characterization of lung cancer tissue.
Schmidt LH; Biesterfeld S; Kümmel A; Faldum A; Sebastian M; Taube C; Buhll R; Wiewrodt R
Anticancer Res; 2009 Jan; 29(1):201-9. PubMed ID: 19331151
[TBL] [Abstract][Full Text] [Related]
16. Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer.
Grob TJ; Hoenig T; Clauditz TS; Atanackovic D; Koenig AM; Vashist YK; Klose H; Simon R; Pantel K; Izbicki JR; Bokemeyer C; Sauter G; Wilczak W
Lung Cancer; 2013 Mar; 79(3):221-7. PubMed ID: 23238037
[TBL] [Abstract][Full Text] [Related]
17. Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer.
Howard BA; Zheng Z; Campa MJ; Wang MZ; Sharma A; Haura E; Herndon JE; Fitzgerald MC; Bepler G; Patz EF
Lung Cancer; 2004 Dec; 46(3):313-23. PubMed ID: 15541816
[TBL] [Abstract][Full Text] [Related]
18. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer.
Jung CK; Jung JH; Park GS; Lee A; Kang CS; Lee KY
Pathol Int; 2006 Sep; 56(9):503-9. PubMed ID: 16930330
[TBL] [Abstract][Full Text] [Related]
19. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
20. Utilization of p40 (ΔNp63) with p63 and cytokeratin 5/6 immunohistochemistry in non-small cell lung carcinoma fine-needle aspiration biopsy.
Collins BT; Wang JF; Bernadt CT
Acta Cytol; 2013; 57(6):619-24. PubMed ID: 24107322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
